Good Faith Estimates: What’s to Know?

In the complex landscape of healthcare, patients often find themselves facing unexpected medical bills, leading to financial strain and confusion. To address this issue, Good Faith Estimates (GFEs) have emerged as a valuable tool. They aim to provide patients with greater financial transparency and empower them to make informed decisions about their healthcare.

Consequently, GFEs are a product of the No Surprises Act, which went into effect in 2022. With transparency undoubtedly becoming a prominent component of the healthcare industry, Good Faith Estimates are already becoming a vital part of any practice or lab involved with diagnostic testing and medical costs. Frequently asked questions about Good Faith Estimates include:

Frequently asked q's about GFE's
Good Faith Estimates: What’s to Know?

Adjusting to this new standard of healthcare can be daunting. If GFEs are creating a burden, we can help. careviso’s product seeQer, specializes in answering the cost and coverage questions plaguing patients, providers, and payors. Furthermore, by identifying out-of-pocket costs in advance, seeQer alleviates the burden associated with GFEs and empowers individuals to make informed decisions about their healthcare.

About careviso

careviso is a healthcare technology company supporting everyone involved in diagnostic testing. We created a proprietary platform for payors, physicians, and laboratories that improves patient care through streamlined workflows. By automating the impossible we’re solving the most complex problems in the healthcare industry: prior authorizations and financial transparency.

Download as PDF
Book your software demo

Discover how seeQer informs patients and transforms practice.

Schedule a seeQer demonstration of benefits verifications, cost assessments, and other essential tasks in the platform. Learn how seeQer can help your organization reduce administrative burden, transform cumbersome processes, and provide transparency that empowers patients in a complex and ever-changing industry.